ProShare Advisors LLC - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 49 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q3 2018$73,000
+23.7%
27,112
+60.0%
0.00%–
Q2 2018$59,000
-30.6%
16,940
-0.1%
0.00%
-100.0%
Q1 2018$85,000
-28.0%
16,965
-14.2%
0.00%0.0%
Q4 2017$118,000–19,767–0.00%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q4 2018.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders